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Background: The role of staging laparoscopy (SL) in patients with incidental gallbladder cancer (IGBC)
is ill defined. This study evaluates the utility of SL with the aim of identifying variables associated with
disseminated disease (DD).
Methods: Consecutive patients with IGBC who underwent re-exploration between 1998 and 2009 were
identified from a prospective database. The yield and accuracy of SL were calculated. Demographics,
tumour- and treatment-related variables were correlated with findings of DD.
Results: Of the 136 patients submitted to re-exploration for possible definitive resection, 19 (14.0%) had
DD. Staging laparoscopy was carried out in 46 (33.8%) patients, of whom 10 (21.8%) had DD (peritoneal
disease [n = 6], liver metastases [n = 3], retroperitoneal disease [n = 1]). Disseminated disease was
identified by SL in two patients (yield = 4.3%), whereas eight were diagnosed after conversion to
laparotomy (accuracy = 20.0%). The likelihood of DD correlated closely with T-stage (T1b, n = 0; T2, n =
5 [7.0%], T3, n = 14 [26.0%]; P = 0.004). A positive margin at initial cholecystectomy (odds ratio [OR] 5.44,
95% confidence interval [CI] 1.51–24.37; P = 0.004) and tumour differentiation (OR 7.64, 95% CI 1.1–NA;
P = 0.006) were independent predictors of DD on multivariate analysis.
Discussion: Disseminated disease is relatively uncommon in patients with IGBC and SL provides a very
low yield. However, patients with poorly differentiated, T3 or positive-margin gallbladder tumours are at
high risk for DD and targeting these patients may increase the yield of SL.
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Introduction
Gallbladder cancer (GBC) diagnosed after elective cholecystec-
tomy for presumed benign disease is defined as incidental gall-
bladder cancer (IGBC).1 Over the past several years, the incidence
of IGBC has increased, probably as a result of the increase in the
number of elective cholecystectomies.2 For selected patients with
invasive tumours in whom restaging does not show disseminated
disease (DD), re-exploration and definitive resection are indicated
and are associated with improved survival.3,4 However, despite
negative findings on high-quality, preoperative imaging studies, a
sizeable proportion (10–57%) of patients will have advanced
disease at re-exploration.2,5
Laparoscopy has been shown to be an important staging tool in
the management of gastrointestinal malignancies because it pro-
vides the ability to identify radiographically occult DD before
proceeding to laparotomy for an attempt at resection.6–8 In the
subgroup of patients with primary and secondary hepatobiliary
cancers, the incidence of occult unresectable disease is high (25–
75%).6 Given these high rates, staging laparoscopy (SL) is fre-
quently utilized in order to decrease lengths of stay and overall
hospital charges in the subgroup of patients with advanced disease
that is not amenable to resection.9–13
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Some authors have recommended using SL to identify DD in all
patients with IGBC undergoing re-operation for planned defini-
tive resection.2 As imaging technology improves, however, an
increasingly larger proportion of patients are identified during
preoperative staging examinations as having unresectable cancer.
Thus, the rationale and potential benefits of SL must be weighed
against the added cost and increased operating time incurred by
using it in patients who are at low risk for DD. The role of SL in
patients with IGBC has not been clearly defined because most
studies have included patients with primary gallbladder tumours,
which appear to have a higher risk for metastatic disease, or those
with findings suspicious for GBC on preoperative imaging.14,15
The heterogeneity of patients included in these studies brings into
question the objective evaluation of patients with IGBC and pre-
vents the drawing of definitive conclusions.
The objectives of this study were to analyse all patients with
IGBC who underwent re-operation at Memorial Sloan-Kettering
Cancer Center (MSKCC). The correlation of operative findings
with various clinical and histopathologic data may help to identify
variables associated with a high likelihood of occult DD and may
thus support the selective targeting of SL towards the patients who
are at greatest risk.
Materials and methods
Subjects and data collection
The study protocol was approved by the Institutional Review
Board at MSKCC, after which records of all patients with IGBC
who underwent re-exploration between 1998 and 2009 were col-
lected and analysed. Incidental GBC was defined as unsuspected
GBC diagnosed histologically after cholecystectomy performed
for presumed benign disease. Data were extracted from a prospec-
tive database and supplemented by the review of individual
medical records. Recorded data included patient demographics,
number and type of preoperative imaging studies, extent of lap-
aroscopic examination, surgical findings and resectability, opera-
tive procedures performed, operative time, perioperative
outcomes, length of hospital stay, tumour histopathology and
staging. Before any re-exploration for possible definitive surgical
treatment was conducted, all cases of IGBC were histopathologi-
cally confirmed at MSKCC by re-examining the primary tumour.
The authors’ approach to patient selection and evaluation has
been reported previously.4,16,17 All patients were re-staged accord-
ing to physical examination and imaging studies (thoracic and
abdominal/pelvic computed tomography [CT], magnetic reso-
nance imaging [MRI] and/or 18F-fluorodeoxyglucose positron
emission tomography [18FDG PET-CT]). Imaging studies
included those performed at referring hospitals and at MSKCC.
The number and type of preoperative staging studies was noted;
findings suggesting residual disease were recorded. All patients
with tumour invasion to at least the muscularis propria layer
(T1b) and without evidence of stage IV disease were advised to
undergo re-exploration and definitive resection.
Special attention was focused on clinical and pathologic fea-
tures related to the initial cholecystectomy and the following
factors were analysed: reason for cholecystectomy; findings on
preoperative abdominal imaging; presence of acute cholecystitis;
emergency vs. elective surgery; type of cholecystectomy (open,
converted to laparoscopic, laparoscopic); disruption of the gall-
bladder during surgery, and use of a specimen bag to extract the
gallbladder (in patients undergoing laparoscopic cholecystec-
tomy). Pathologic factors evaluated were: depth of tumour inva-
sion; presence of inflammation; presence of gallstones and/or
polyps; histology and grade of differentiation; presence of
perineural and/or lymphovascular invasion; margin status, and
lymph node involvement.
Final disease staging was based on the sixth edition of the
American Joint Committee on Cancer (AJCC) manual.18
Operative approach
The authors’ operative approach to the resection of GBC has been
documented previously.4,16,17 At the discretion of the attending
surgeon, SL was performed just prior to laparotomy to exclude
metastatic disease. A complete laparoscopic examination of the
abdominal cavity included inspection of the liver, gastrohepatic
ligament, porta hepatis, pelvis and peritoneal cavity. If these areas
could not be visualized at least partially, laparoscopy was consid-
ered incomplete. In selected patients, laparoscopic exploration
was complemented with laparoscopic ultrasound (US), using an
Aloka US imaging system with a 7.5-MHz flexible laparoscopic
probe (UST-5536; Aloka Co. Ltd, Tokyo, Japan). Laparoscopic US
was used to assess the liver for evidence of metastatic disease and
tumour extent within the porta hepatis. Patients who appeared to
have localized, resectable disease at laparoscopy underwent a lap-
arotomy. Open exploration included mobilization and palpation
of the liver, duodenum, head of the pancreas and retroperito-
neum, and ultrasonography of the liver. Biopsies were taken if any
suspicious hepatic or extrahepatic lesions were identified and were
evaluated with frozen-section pathology.
Tumours were considered unresectable, at either laparoscopy or
laparotomy, if any one of the following findings of DD was iden-
tified: peritoneal metastases; intrahepatic metastases (outside the
gallbladder fossa), and involved lymph nodes outside the porta
hepatis basin (i.e. paraduodenal, retropancreatic, common
hepatic artery/coeliac artery). Involvement of proximal porta
hepatis lymph nodes did not necessarily contraindicate resection.
In addition, locally advanced disease with extensive infiltration
into the porta hepatis generally precluded resection, although this
finding is uncommon in IGBC. Disseminated disease was chosen
as the primary endpoint of the study because it is the most
common reason for unresectability in patients with IGBC and it
can be straightforward to identify laparoscopically.
The degree of liver resection selected was based on the extent of
disease and possible involvement of major inflow pedicle struc-
tures. Major hepatectomy was defined as a right or left hepatec-
tomy or extended hepatectomy. Minor hepatectomy was defined
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as resection of segments IVB and V or less. Major resection was
performed if there was definite tumour or inflammatory tissue
indistinguishable from tumour, involving major inflow vascular
structures. Common bile duct resection was performed when
there was definite or suspected involvement that mandated this
extent of resection in order to achieve clear margins. The lym-
phadenectomy included nodal tissue in the porta hepatis and
portocaval basins and along the common hepatic artery.
Operative time (total and laparoscopic), blood loss, periopera-
tive outcomes and length of hospital stay were recorded. Surgical
mortality was defined as death resulting from postoperative com-
plications at any time after surgery.
Pathologic examination
In all patients, the surgical pathology material obtained at the
initial cholecystectomy was re-reviewed to confirm the final diag-
nosis. For this analysis, special emphasis was placed on the depth
of tumour invasion, presence of inflammation, factors associated
with cancer (gallstones and/or polyps), tumour histology and
grade of differentiation, and the presence of perineural and/or
lymphovascular invasion. A positive margin was defined as a
margin of <1 mm and lymph node involvement (N1 disease) as
tumoral involvement in at least one lymph node resected. Depth
of tumour invasion was defined according to the AJCC staging
manual.18 Histologic types were categorized as adenocarcinoma,
squamous cell carcinoma, adenosquamous cell carcinoma, neu-
roendocrine tumour and undifferentiated. Histologic differentia-
tion was categorized as well, moderate or poorly differentiated.
Statistical analysis
Variables were summarized using proportions (categorical) or
mean  standard deviation and median (range [continuous]).
Characteristics of patients with disseminated vs. non-
disseminated disease were compared using Fisher’s exact test for
categorical variables and Wilcoxon’s signed rank test for continu-
ous variables. The laparoscopic yield was calculated by dividing
the number of patients with unresectable or disseminated disease
by the number of patients undergoing laparoscopy. The accuracy
of SL was calculated by dividing the number of patients with
findings of unresectable disease at laparoscopy by the number of
all patients with unresectable disease. The relationship between
T-stage and DD was calculated using the chi-squared test, the
relationship between T-stage and laparoscopic yield was calcu-
lated using the Cochran–Armitage test, and the relationship
between T-stage and laparoscopic accuracy was calculated using
Fisher’s exact test.
A univariate Cox proportional hazards regression model was
used to identify factors individually predictive of DD in all
patients (n = 136) who submitted to re-operation. All variables
that were significant at the 10% level on univariate analysis were
entered into a multivariate model using logistic regression.
All tests were two-sided and statistical significance was defined as
P < 0.05. Statistical analysis was performed using sas Version 9.2
(SAS Institute, Inc., Cary, NC, USA).
Results
Clinical presentation
Between 1998 and 2009, 136 patients with IGBC underwent
re-exploration at MSKCC (Fig. 1). Re-staging was performed by
laparotomy in 90 patients and by laparoscopy in 46. Nineteen
patients (14.0%) were found to have DD at the time of
re-exploration. Nine of the patients (10.0%) restaged with laparo-
tomy (i.e. no laparoscopy) and 10 of the patients (21.8%) initially
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Re-exploration
Laparotomy
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Figure 1 Type of re-exploration and findings in patients with incidental gallbladder treated at Memorial Sloan-Kettering Cancer Center
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explored laparoscopically had DD (P = 0.07) (Table 1). In the
entire cohort of 136 patients with IGBC, demographic and patho-
logic differences emerged between patients explored by laparo-
tomy and those explored laparoscopically. The laparotomy group
(median age 63 years, range 28–85 years) was younger than the
laparoscopy group (median age 66 years, range 41–90 years) (P =
0.01) and had a higher incidence of gallbladder inflammation
(n = 135) (77.5% [n = 69] vs. 56.5% [n = 26]; P = 0.01) and
perineural invasion (n = 100) (55.6% [n = 30] vs. 34.8% [n = 16];
P = 0.04) in the initial cholecystectomy specimen.
The 46 patients in the laparoscopy group included 29 women
and 17 men. Before cholecystectomy, the majority of patients had
abdominal pain (n = 42), three were asymptomatic and one pre-
sented with jaundice. The most frequent finding in preoperative
US was gallstones (n = 32). Thickening of the gallbladder wall was
observed in nine patients, a gallbladder polyp in two, gallbladder
sludge in two and a mass in one. The most common preoperative
diagnosis was acute cholecystitis (n = 29) and 25 patients under-
went emergency surgery. Complete laparoscopic cholecystectomy
was performed in 38 patients, laparoscopic cholecystectomy was
converted to open surgery in seven cases and one patient under-
went an open procedure with no laparoscopy. Thirteen patients
suffered disruption of the gallbladder wall during cholecystec-
tomy. The gallbladder was extracted in a bag in 17 of 25 patients
who underwent a total laparoscopic procedure and for whom this
information was available.
Pathology
The initial cholecystectomy specimen was re-examined in all 136
patients with IGBC, revealing compromise of the muscularis
propria layer (T1b) in 14 (10.3%) patients, the perimuscular con-
nective tissue (T2) in 68 (50.0%), and the serosal layer or invasion
of the liver tissue (T3) in 54 (39.7%). A total of 125 (91.9%)
patients were found to have gallstones and 12 (8.8%) had gall-
bladder polyps. Acute or chronic inflammation was seen in 95
(70.0%) patients. In total, 124 (91.2%) patients had an adenocar-
cinoma, eight (5.9%) patients had an adenosquamous cell carci-
noma, two (1.5%) patients had a squamous cell carcinoma and
two (1.5%) patients had an endocrine tumour. Tumour grading
was well differentiated in 15 patients, moderately differentiated in
67, poorly differentiated in 52 and unknown in two patients.
Lymphovascular invasion was evaluated in 105 patients, in 53 of
whom it was found to be positive. Perineural invasion was
observed in 46 of 100 patients evaluated. Positive margins were
found in 61 (44.8%) patients after cholecystectomy; the gallblad-
der bed was the most common site (32 patients), followed by the
cystic duct (25 patients), and both the gallbladder bed and cystic
duct (four patients). The cystic duct lymph node was analysed in
34 (25.0%) patients and was involved by tumour in 19 of them.
In the subgroup of 46 patients who underwent SL,
re-examination of the initial cholecystectomy specimen showed
compromise of the muscularis propria layer (T1b) in six patients,
the perimuscular connective tissue (T2) in 26 patients, and the
serosal layer or invasion of the liver tissue (T3) in 14 patients.
Forty patients had gallstones and six had gallbladder polyps.Acute
or chronic inflammation was seen in 26 patients. Forty-four
patients had an adenocarcinoma, one had a squamous cell carci-
noma and another had an endocrine tumour. Three patients had
well-differentiated tumours, 20 patients had moderately differen-
tiated tumours and 23 had poorly differentiated tumours. Lym-
phovascular invasion was present in 20 patients and perineural
invasion was observed in 16. A positive margin after cholecystec-
tomy was noted in 20 patients. The most common site of involve-
ment was the gallbladder bed (10 patients), the cystic duct (eight
patients) and both the gallbladder bed and cystic duct (two
patients). The cystic duct lymph node was analysed in 12 patients
and was involved by tumour in eight of these.
Imaging studies before re-exploration
The type of staging imaging studies utilized prior to
re-exploration was evaluated for the entire cohort of 136 patients
with IGBC. All patients were restaged with at least one cross-
sectional imaging study and external imaging studies were
reviewed at MSKCC. Abdominal CT was used in 95 patients and
indicated possible residual disease in 29 of them.Abdominal MRI/
cholangio-MRI was used in 57 patients and indicated possible
residual disease in 11; PET-CT was used in 32 patients and indi-
cated possible residual disease in 10.Abdominal US was used in 13
patients and indicated possible residual disease in three. Overall,
79 patients were restaged with one modality, 52 with two modali-
ties and four with three modalities. The median number of
imaging studies (CT, MRI/cholangio-MRI, PET-CT, abdominal
US) analysed before re-exploration was one (range: 1–3 images)
and the median number of studies suspicious of intra- or extra-
abdominal disease was zero (range: 0–2 images).
Re-exploration
The median time between cholecystectomy and surgical
re-exploration was 2 months (range: 1–13 months). Staging lap-
aroscopy was performed as a separate procedure in one of 46
patients. This patient was returned to the operating room for
laparotomy at a later date. In the remaining 45 patients, laparos-
copy was performed immediately prior to planned laparotomy
and definitive resection. Laparoscopy was considered complete in
all patients and identified DD (carcinomatosis) that precluded
laparotomy and re-resection in two patients. The remaining 44
patients underwent laparotomy, which identified DD that pre-
cluded resection in eight patients, of whom four had peritoneal
disease, three had liver metastases, and one had retroperitoneal
nodal disease. Thus, the yield of laparoscopy was 4.3% (two of 46
patients explored) and its accuracy was 20% (two of 10 patients
with DD). The yield and accuracy of laparoscopy increased from
0% to 14.3% (P = 0.06) and from 0% to 33.3% (P = 0.47), respec-
tively, when correlated with the depth of tumour invasion in the
gallbladder wall (Table 2).
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Table 1 Comparison between patients with incidental gallbladder cancer and disseminated disease based on type of re-exploration
All patients Open procedure group Laparoscopy group P-value
Gender, n (%) 0.1
Female 11 (57.9) 7 (77.8) 4 (40.0)
Male 8 (42.1) 2 (22.2) 6 (60.0)
Age, years, median (range) 63 (40–90) 61 (40–77) 66 (56–90) 0.3
Reason for cholecystectomy, n (%) 1
Abdominal pain 18 (94.7) 9 (100) 9 (90.0)
Wall thickening 1 (5.3) 0 1 (10.0)
Abdominal ultrasound findings, n (%) 0.5
Gallstones 9 (47.4) 5 (55.6) 4 (40.0)
Wall thickening 9 (47.4) 4 (44.4) 5 (50.0)
Sludge 1 (5.3) 0 1 (10.0)
Cholecystectomy, n (%)
Acute cholecystitis 14 (73.7) 7 (77.8) 7 (70.0) 1
Emergency surgery 10 (52.6) 3 (33.3) 7 (70.0) 0.1
Type of surgery, n (%) 0.5
Laparoscopic 10 (52.6) 4 (44.4) 6 (60.0)
Laparoscopic converted to open 8 (42.1) 4 (44.4) 4 (40.0)
Open 1 (5.3) 1 (11.1) 0
Disruption of gallbladder wall, n (%) 10 (52.6) 5 (55.6) 5 (50.0) 1
Pathologic examination, n (%)
T-stagea 0.3
T2 5 (26.3) 1 (11.1) 4 (40.0)
T3 14 (74.7) 8 (88.9) 6 (60.0)
Inflammation 16 (84.2) 9 (100) 7 (70.0) 0.2
Gallstones associated 18 (94.7) 9 (100) 9 (9.0) 1
Tumour type 0.3
Adenocarcinoma 16 (84.2) 7 (77.8) 9 (90.0)
Adenosquamous 1 (5.3) 1 (11.1) 0
Squamous 1 (5.3) 1 (11.1) 0
Endocrine 1 (5.3) 0 1 (1.0)
Grade 0.1
Moderated 5 (26.3) 4 (44.4) 1 (10.0)
Poor 14 (74.7) 5 (55.6) 9 (90.0)
Lymph nodes status 0.2
Negative 2 (10.5) 2 (22.2) 0
Positive 5 (26.3) 2 (22.2) 3 (30.0)
Unknown 12 (63.2) 5 (55.6) 7 (70.0)
Lymphovascular invasion (n = 18) 11 (61.1) 4 (50.0) 7 (70.0) 0.6
Perineural invasion (n = 16) 11 (68.8) 4 (66.7) 7 (70.0) 1
Positive cholecystectomy margin 15 (78.9) 8 (88.9) 7 (70.0) 0.5
Liver 6 (40.0) 5 (62.5) 1 (14.3) 0.1
Cystic duct 6 (40.0) 2 (25.0) 4 (57.1) 0.1
Liver + cystic duct 3 (20.0) 1 (12.5) 2 (28.6) 0.1
Preoperative imaging studies (staging), median (range) 1 (1–3) 1 (1–3) 1 (1–2) 0.5
Studies suggesting residual disease, median (range) 1 (0–2) 1 (0–2) 0 (0–2) 0.2
Time between surgeries, months, median (range) 2 (1–5) 2 (1–5) 2 (1–3) 0.6
Re-exploration
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Comparison of patients with disseminated and
localized disease
Of the 136 patients with IGBC, 19 (14.0%) were found to have DD
during surgical exploration. There were no differences in gender,
age or symptoms before cholecystectomy among patients with
disseminated (n = 19) and localized (n = 117) disease. However,
patients with DD had a higher incidence of gallbladder wall thick-
ening on pre-cholecystectomy US (47.4% [n = 9] vs. 19.7% [n =
23]; P = 0.016), a higher incidence of conversion from laparo-
scopic to open cholecystectomy (42.1% [n = 8] vs. 17.1% [n = 20];
P = 0.04), a higher proportion of stage T3 tumours (73.7% [n =
14] vs. 34.2% [n = 40]; P = 0.02), more poorly differentiated
tumours (73.7% [n = 14] vs. 32.5% [n = 38]; P = 0.01), a positive
cholecystectomy margin (78.9% [n = 15] vs. 39.7% [n = 46]; P =
0.002), and a higher number of re-staging imaging studies sug-
gesting residual cancer before re-exploration (median = 1 [range:
0–2] vs. median = 0 [range: 0–2]; P = 0.02) than patients with
localized disease. The likelihood of DD after cholecystectomy was
closely related to the T-stage of the cholecystectomy specimen
(Table 2).
Univariate and multivariate analyses
Univariate analysis of the entire cohort (n = 136) showed
that thickening of the gallbladder wall observed on pre-
cholecystectomy US, the conversion of laparoscopic to open
cholecystectomy, T3 and poorly differentiated tumours, positive
cholecystectomy margin, and a greater number of re-staging
imaging studies suggesting residual disease were associated with
DD at re-exploration. Multivariate analysis showed that only a
positive margin at cholecystectomy (odds ratio [OR] 5.44, 95%
confidence interval [CI] 1.51–24.37) and a poorly differentiated
tumour (OR 7.64, 95% CI 1.1–NA) were independent predictors
associated with disseminated or unresectable disease during
re-exploration of IGBC (Table 3).
Discussion
Gallbladder cancer is an uncommon and aggressive malignancy,
and a high proportion of patients have advanced-stage disease at
presentation.19,20 Over the past several years, incidental diagnosis
after cholecystectomy for presumed benign disease has increased
and is now the most common reason for presentation.
Re-exploration with complete resection is the treatment of choice
in patients with localized disease;4,16,21–23 however, radiographically
occult DD is found at re-exploration in a subgroup of these
patients (24–46%).5,19,24 A number of prior studies have shown
that laparoscopy is an effective staging tool for many abdominal
malignancies, particularly those of hepatopancreatobiliary origin,
which include a high proportion of occult metastatic disease that
can be detected laparoscopically.9,11–13,25–27
The results of the present study show that the incidence of DD
in patients undergoing re-exploration for IGBC was relatively low
Table 1 Continued
All patients Open procedure group Laparoscopy group P-value
Disseminated disease, n (%) 19 (14.0) 9 (10.0) 10 (21.8) 0.07
Length of procedure, min, median (range) 120 (60–480) 120 (90–480) 139 (60–186) 0.6
Blood loss, ml, median (range) 50 (40–1200) 50 (40–1200) 50 (50–200) 0.9
Complications, n (%) 3 (15.8) 0 3 (30.0) 1
Atrial fibrillation, n 2 0 2
Wound infection, n 1 0 1
Length of hospital stay, days, median (range) 5 (1–12) 4 (3–12) 5 (1–9) 0.8
Definition of disseminated disease, n (%) 0.08
Carcinomatosis 11 (57.9) 5 (55.5) 6 (60.0)
Liver metastases 3 (15.8) 0 3 (30.0)
N3 disease 5 (26.3) 4 (44.4) 1 (10.0)
aNone of the patients with T1b tumours had disseminated disease.
Table 2 Relationships between T-stage and yield and accuracy of laparoscopy
T-stage All patients
(n = 136)
n (%)
SL group
(n = 46)
n (%)
DDa
All patients
n (%)
DD at
laparoscopy,
n
DD
after SL,
n
Yieldb
n (%)
Accuracyc
n (%)
1b 14 (10.3) 6 (13.0) 0 0 0 0/6 –
2 68 (50.0) 26 (56.5) 5 (7.4) 0 4 0/26 0/4
3 54 (39.7) 14 (30.4) 14 (25.9) 2 6 2/14 (14.3) 2/6 (33.3)
aP = 0.004, chi-squared test; bP = 0.06, Cochran–Armitage test; cP = 0.47, Fisher's exact test.
SL, staging laparoscopy; DD, disseminated or unresectable disease.
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Table 3 Univariate and multivariate analysis of variables associated with disseminated or unresectable disease in patients with incidental
gallbladder cancer submitted to re-exploration
Variable All patients
(n = 136)
Non-DD group
(n = 117)
n (%)
DD group
(n = 19)
n (%)
P-value,
univariate
P-value,
multivariate
Hazard
ratio
95%
CI
Gender 0.53
Female 93 82 (88.2) 11 (11.8)
Male 43 35 (81.4) 8 (18.6)
Age, years 0.2
Mean  standard deviation 64  11 64  10 67  14
Median (range) 65 (28–90) 65 (28–85) 63 (40–90)
Presentation of disease 0.97
Abdominal pain 126 108 (85.7) 18 (14.3)
Abnormal study 7 6 (87.7) 1 (12.3)
Jaundice 1 1 (100) 0
Nausea 1 1 (100) 0
Pancreatitis 1 1 (100) 0
Gallstones on pre-cholecystectomy US 0.066
Yes 91 82 (90.1) 9 (9.9)
No 45 35 (77.8) 10 (22.2)
GB wall thickening on pre-cholecystectomy
US
0.016
Yes 32 23 (71.9) 9 (28.1)
No 104 94 (89.6) 10 (10.4)
Acute cholecystitis 0.4
Yes 87 73 (83.9) 14 (16.1)
No 48 43 (89.6) 5 (10.4)
Emergency cholecystectomy 1
Yes 73 63 (86.3) 10 (13.7)
No 62 53 (85.5) 9 (14.5)
Type of cholecystectomy 0.044
Open 11 10 (90.9) 1 (9.1)
Laparoscopic converted to open 28 20 (71.4) 8 (28.6)
Laparoscopic 97 87 (89.7) 10 (10.3)
Disruption of gallbladder wall 0.2
Yes 47 37 (78.7) 10 (21.3)
No 73 64 (87.7) 9 (12.3)
T-stage 0.025
1b 14 14 (100) 0
2 68 63 (92.6) 5 (7.4)
3 54 40 (74.1) 14 (25.9)
Inflammation 0.18
Yes 95 79 (83.2) 16 (16.8)
No 40 37 (92.5) 3 (7.5)
Gallstones 1
Yes 125 107 (85.6) 18 (14.4)
No 11 10 (90.9) 1 (9.1)
Gallbladder polyp 0.2
Yes 12 12 (100) 0
No 124 105 (84.7) 19 (15.3)
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at 14.0%, and that the yield and accuracy of laparoscopic
re-staging were equally low. Indeed, the results were inferior to
those reported for SL in previous publications, although it must
be emphasized that these studies included patients at greater risk
for DD, specifically comprising patients with primary GBC and
patients with symptoms caused by GBC.9,11,14,15,28 Thus, clinical
presentation would appear to be a useful criterion in the selection
of GBC patients for SL, but its utility in patients with IGBC is
likely to be very low because symptoms are often absent in this
subgroup. Other factors potentially contributing to the low yield
of SL refer to the relatively small number of events (i.e. of DD) and
bias related to patient selection for the procedure. The latter
would seem less likely, however, given the absence of differences in
the rate of DD, demographics, and pathology-, treatment- and
outcome-related variables between the laparoscopic and open
exploration groups.
It has previously been shown that, despite the utility of SL in
GBC in general terms, a lower yield can be expected in patients
with IGBC. In a study of 401 patients with hepatobiliary malig-
nancies,11 the highest yield of SL was found in the subset of
patients with GBC, nearly 50% of whom were spared a laparo-
tomy; however, in a subsequent analysis focusing on patients with
biliary cancer, the yield of SL decreased significantly in the sub-
group of patients with IGBC (20%).28 Similar results were
observed by Agrawal et al.9 in a study of laparoscopic staging in 91
patients with suspected GBC.
Table 3 Continued
Variable All patients
(n = 136)
Non-DD group
(n = 117)
n (%)
DD group
(n = 19)
n (%)
P-value,
univariate
P-value,
multivariate
Hazard
ratio
95%
CI
Tumour type 0.2
Adenocarcinoma 124 108 (87.1) 16 (12.9)
Adenosquamous 8 7 (87.5) 1 (12.5)
Squamous 2 1 (50.0) 1 (50.0)
Neuroendocrine 2 1 (50.0) 1 (50.0)
Grade of differentiation 0.015 0.006
Good 15 15 (100) 0 Ref.
Moderate 67 62 (92.5) 5 (7.5) 1.77 0.22–NA
Poor 52 38 (73.1) 14 (26.9) 7.64 1.10–NA
Lymph node status 0.2
Negative 15 13 (86.7) 2 (13.3)
Positive 19 14 (73.7) 5 (26.3)
Unknown 102 90 (88.2) 12 (11.8)
Lymphovascular invasion 0.4
Present 53 42 (79.2) 11 (20.8)
Absent 52 45 (86.5) 7 (13.5)
Perineural invasion 0.058
Present 46 35 (76.1) 11 (23.9)
Absent 54 49 (90.7) 5 (9.3)
Positive cholecystectomy margin 0.002 0.004
Yes 61 46 (75.4) 15 (24.6) 5.44 1.51–24.37
No 74 70 (94.6) 4 (5.4)
Site of positive margin <0.0001
Gallbladder bed 32 26 (81.3) 6 (18.8)
Cystic duct 25 19 (76.0) 4 (16.0)
Gallbladder bed + cystic duct 4 1 (25.0) 3 (75.0)
Negative margin 74 70 (94.6) 4 (5.4)
Studies suggesting residual disease 0.02
Mean  standard deviation 0.38  0.6 0.33  0.6 0.68  0.7
Median (range) 0 (0–2) 1 (1–3) 1 (0–2)
DD, disseminated or unresectable disease; US, ultrasound; GB, gallbladder.
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Given the history of recent abdominal exploration at the time
of the original cholecystectomy procedure, the lower yield of SL in
patients with IGBC, compared with those with primary GBC, is
understandable. The original procedure was, however, performed
for a diagnosis that was presumed to be benign and was not
undertaken to specifically assess for metastatic cancer. Neverthe-
less, the procedure might have been expected to identify many
patients in whom such findings were available. Whether evidence
of advanced cancer was present at the time of the initial cholecys-
tectomy and was not appreciated, or whether it arose as a direct
result of the laparoscopic procedure is a matter of conjecture. The
direct and significant correlation between T-stage and DD
observed in this study may be cited in support of the latter
hypothesis because violation of the tumour plane is much more
likely to occur with T3 tumours.
The results of the present study showed the overall yield of SL
to be low, but indicated the presence of a subset of patients with
an elevated risk for metastatic disease who should potentially be
offered this procedure. Analysis of the clinical presentation, find-
ings related to the initial cholecystectomy, particularly a com-
plete histopathologic review, and re-staging imaging studies may
predict the risk for tumour dissemination and support the
rational selection of patients for laparoscopic staging. Specifi-
cally, disruption of the gallbladder wall during cholecystectomy,
T-stage, tumour grade or differentiation, lymphovascular and
perineural invasion, a positive margin, and metastasis to the
cystic duct lymph node have been associated with residual
and/or disseminated disease, recurrence and longterm survival
in prior studies of patients with IGBC.5,17,29–32 The current study
showed that margin status at the initial cholecystectomy and a
poorly differentiated tumour were independent factors associ-
ated with the occurrence of DD during re-exploration of IGBC.
In addition, there was a strong and significant correlation
between T-stage and the finding of DD. These variables may
therefore be useful in identifying the subset of patients at the
highest risk for DD for staging laparoscopy, thereby improving
the yield.
It should be noted that eight of the 10 patients with DD who
underwent SL were not identified during this procedure.Whether
this represents a failure of the technique itself (i.e. the disease was
not identifiable) or its application (i.e. the examination was not as
thorough as it should have been) is impossible to know. Four
patients had low-volume peritoneal disease, three had liver
metastases, and another had retroperitoneal nodal disease. Adhe-
sions to the gallbladder bed appeared to be the main cause of the
failure to identify DD in the patients with peritoneal disease. By
contrast, hepatic and retroperitoneal metastases were found only
after conversion to laparotomy and palpation of the metastatic
disease. Similar findings regarding the identification of lymph
node or subcapsular hepatic metastases have been reported in
prior studies.25,28,29 The results underscore the need for a thorough
and rigorous laparoscopic staging procedure, particularly in high-
risk patients.
In summary, the yield and accuracy of SL in this cohort of
patients with IGBC were lower than those reported previously.
Most other studies included symptomatic patients with preopera-
tive suspicion of DD. The higher yield of laparoscopy in these
studies suggests that the yield depends on symptoms at presenta-
tion. The present study showed that a positive cholecystectomy
margin and poor tumour differentiation were independent factors
associated with the finding of DD at re-exploration. Furthermore,
the likelihood of DD correlated with T-stage and was present in
over one-quarter of patients with T3 tumours. Staging laparos-
copy has a limited role in patients with IGBC. The only patients
for whom the procedure should be considered are those with
adverse clinical factors such as high T-stage, a positive pathologic
margin and high tumour grade.
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